Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A patient with complete hair loss regrew all her hair using tofacitinib.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Raltegravir may cause hair loss in some patients.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Glibenclamide slows breast cancer cell growth by stopping cell division.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

A patient's grey hair regained color during treatment with adalimumab.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Upadacitinib may cause hair loss.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Tofacitinib, a hair regrowth treatment, may worsen acne.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.